tiprankstipranks
Trending News
More News >
Meghmani Organics Limited (IN:MOL)
:MOL
India Market
Advertisement

Meghmani Organics Limited (MOL) AI Stock Analysis

Compare
0 Followers

Top Page

IN:MOL

Meghmani Organics Limited

(MOL)

Rating:43Neutral
Price Target:
₹84.00
▼(-1.64% Downside)
The overall stock score for Meghmani Organics Limited is primarily impacted by its weak financial performance and bearish technical indicators. The negative P/E ratio and lack of dividend yield further contribute to a low valuation score. The absence of earnings call data and corporate events means these factors do not influence the score.

Meghmani Organics Limited (MOL) vs. iShares MSCI India ETF (INDA)

Meghmani Organics Limited Business Overview & Revenue Model

Company DescriptionMeghmani Organics Limited (MOL) is an India-based diversified chemical company with a strong presence in the agrochemicals and pigments sectors. The company specializes in the manufacture and distribution of a wide range of chemical products, including pesticides, intermediates, and other specialty chemicals. These products cater to various industries such as agriculture, textiles, and plastics, ensuring high-quality standards and compliance with international regulations.
How the Company Makes MoneyMeghmani Organics Limited generates revenue primarily through the production and sale of its chemical products. The company's key revenue streams include the sale of agrochemicals, which are used extensively in the agriculture sector to protect crops and enhance yields, and pigments, which are used in industries like textiles and plastics for coloring purposes. The company also leverages strategic partnerships and global distribution networks to expand its market reach and optimize its supply chain, contributing significantly to its earnings. Additionally, Meghmani Organics benefits from economies of scale in its manufacturing operations, allowing it to maintain competitive pricing and profitability.

Meghmani Organics Limited Financial Statement Overview

Summary
Meghmani Organics Limited is experiencing financial difficulties, highlighted by declining revenues, negative net income, and high leverage. Improvements in some operational margins are overshadowed by negative cash flows and profitability inefficiencies, indicating a need for strategic initiatives to enhance liquidity and profitability.
Income Statement
45
Neutral
The company displays declining revenue with negative growth in the recent year. Gross and net profit margins have been volatile, with the latest year showing a negative net income, impacting the overall profitability. While the EBIT margin has improved, EBITDA margin remains relatively low, indicating potential operational inefficiencies.
Balance Sheet
55
Neutral
The balance sheet shows a high debt-to-equity ratio, suggesting increased leverage and potential financial risk. The equity ratio is moderate, reflecting a balanced asset financing structure. Return on equity has been negative recently, indicating challenges in generating shareholder value.
Cash Flow
40
Negative
The cash flow statement reveals negative free cash flow over the past years, signaling potential liquidity issues. The operating cash flow is insufficient to cover capital expenditures, affecting the company's ability to fund operations without external financing. The free cash flow to net income ratio highlights a disconnect between profitability and cash generation.
BreakdownTTMDec 2025Dec 2023Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue20.80B21.24B25.57B15.48B24.73B16.12B
Gross Profit7.65B8.60B10.42B3.17B10.01B6.93B
EBITDA1.66B1.87B4.10B119.50M4.81B3.11B
Net Income-106.01M-106.01M2.38B-1.06B3.04B1.86B
Balance Sheet
Total Assets30.85B30.85B31.98B30.40B27.98B19.74B
Cash, Cash Equivalents and Short-Term Investments311.77M311.77M1.52B330.74M117.22M1.23B
Total Debt8.29B8.29B8.24B8.37B4.99B2.68B
Total Liabilities15.70B15.70B15.29B15.12B13.31B8.01B
Stockholders Equity15.15B15.15B16.69B15.28B14.66B11.73B
Cash Flow
Free Cash Flow0.00-226.88M-2.61B-165.29M-1.79B1.24B
Operating Cash Flow0.00662.22M2.04B2.50B648.32M3.33B
Investing Cash Flow0.00309.70M-4.18B-1.78B-1.33B-3.07B
Financing Cash Flow0.00-913.88M2.34B-854.77M577.19M-142.40M

Meghmani Organics Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price85.40
Price Trends
50DMA
95.15
Negative
100DMA
83.65
Positive
200DMA
83.61
Positive
Market Momentum
MACD
-2.33
Positive
RSI
35.20
Neutral
STOCH
8.07
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Negative. The current price of 85.4 is below the 20-day moving average (MA) of 95.35, below the 50-day MA of 95.15, and above the 200-day MA of 83.61, indicating a neutral trend. The MACD of -2.33 indicates Positive momentum. The RSI at 35.20 is Neutral, neither overbought nor oversold. The STOCH value of 8.07 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MOL.

Meghmani Organics Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
₹26.12B23.92
0.35%-8.66%-17.63%
69
Neutral
₹26.49B25.22
0.89%2.73%-11.40%
63
Neutral
₹24.73B345.69
0.19%2.47%-72.80%
60
Neutral
₹22.25B63.43
0.64%6.88%94.21%
52
Neutral
₹10.52B310.83
2.51%-0.66%-125.21%
44
Neutral
AU$1.54B-7.28-27.94%4.40%-3.13%-36.41%
43
Neutral
₹21.72B
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:MOL
Meghmani Organics Limited
83.39
-3.85
-4.41%
IN:DCW
DCW Ltd.
73.97
-0.51
-0.68%
IN:FCL
Fineotex Chemical Limited
236.55
-114.20
-32.56%
IN:IOLCP
IOL Chemicals & Pharmaceuticals Ltd.
90.25
13.94
18.27%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,057.25
108.10
11.39%
IN:TNPL
Tamil Nadu Newsprint & Papers Ltd.
152.00
-69.60
-31.41%

Meghmani Organics Limited Corporate Events

Meghmani Organics Approves Key Resolutions at 6th AGM
Jun 30, 2025

Meghmani Organics Limited held its 6th Annual General Meeting on June 28, 2025, where all resolutions were approved with the requisite majority. The meeting, conducted via video conferencing, included the adoption of audited financial statements and the reappointment of directors, reflecting the company’s commitment to transparency and governance.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 07, 2025